Tobira Therapeutics
AcquiredSouth San Francisco, United States · Founded 2006
- Headquarters
- South San Francisco, California
- Employees
- 11–50
- Founded
- 2006
- Business Model
- B2B
- Last Round
- Venture RoundAug 2014
- Rounds
- 1
- Acquired by
- AllerganSep 2016
About
Tobira Therapeutics was a clinical-stage biopharmaceutical company founded in 2006 and headquartered in South San Francisco, California, focused on developing and commercializing therapeutics for liver disease, including non-alcoholic steatohepatitis (NASH), inflammation, fibrosis, and HIV. The company traded on Nasdaq under the ticker TBRA before being acquired by Allergan in 2016 for approximately $1.7 billion, expanding Allergan's global gastrointestinal R&D pipeline.
Summary
Tobira Therapeutics is a Biotech company based in South San Francisco, United States, founded in 2006. Its most recent funding was a Venture Round round in Aug 2014. Investors include Allergan.
Funding History
Sep 2016
Sign up to see all 3 rounds
Venture Round through Acquisition — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/tobira-therapeutics"><img src="https://indexed.vc/api/badge/company/tobira-therapeutics" alt="Tobira Therapeutics on Indexed.vc" width="260" height="76" /></a>